Feasibility, safety and long-term outcomes of complex left main bifurcation treatment using the nano-inverted-t stenting: a multicentre prospective registry.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 04 05 2020
accepted: 10 11 2020
pubmed: 18 11 2020
medline: 6 7 2021
entrez: 17 11 2020
Statut: ppublish

Résumé

The role of double stenting techniques in distal bifurcation left main (LM) disease has gaining interest over the latest years. We present the 3-year multicentre registry outcomes of dual stenting using ultra-thin strut stents and the Nano-Inverted-T (NIT) technique in complex unprotected true LM bifurcation disease. We analysed the procedural and medical data of consecutive patients enrolled between 1st January 2014 and 1st December 2019 in a multicentre registry for complex LM bifurcation disease treated with the double stenting technique called NIT due contraindications and/ or refusal to surgical treatment. Target lesion failure (TLF) was defined as the composite of cardiovascular death, target-vessel MI (TVMI) and clinically driven target lesion revascularization (TLR). Among two hundred-ninety-five patients (138 males, mean age 70.3 ± 12.8 years), post-operative success was achieved in 100% of cases. Contrast volume, procedural time, and radiation exposure were 139.2 ± 23.4 ml, 15.3 ± 4.9 min, and 1080 ± 1034 cGy/m

Identifiants

pubmed: 33200318
doi: 10.1007/s10554-020-02106-x
pii: 10.1007/s10554-020-02106-x
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1107-1119

Références

Banning AP, Lassen JF, Burzotta F, Lefèvre T, Darremont O, Hildick-Smith D, Louvard Y, Stankovic G (2019) Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club. EuroIntervention 15:90–98
doi: 10.4244/EIJ-D-19-00144
Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH, NOBLE study investigators (2016) Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 388:2743-2752
Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM 3rd, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Pagé P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP, Trial Investigators EXCEL (2016) Everolimus-Eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 375:2223–2235
doi: 10.1056/NEJMoa1610227
Kim YH, Lee JH, Roh JH, Ahn JM, Yoon SH, Park DW, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Seung KB, Shin WY, Lee NH, Lee BK, Lee SG, Nam CW, Yoon J, Yang JY, Hyon MS, Lee K, Jang JS, Kim HS, Park SW, Park SJ (2015) Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis. JACC Cardiovasc Interv 8:550–560
doi: 10.1016/j.jcin.2015.01.016
Zimarino M, Briguori C, Amat-Santos IJ, Radico F, Barbato E, Chieffo A, Cirillo P, Costa RA, Erglis A, Gamra H, Gil RJ, Kanic V, Kedev SA, Maddestra N, Nakamura S, Pellicano M, Petrov I, Strozzi M, Tesorio T, Vukcevic V, De Caterina R, Stankovic G, Club EuroBifurcation (2019) Mid-term outcomes after percutaneous interventions in coronary bifurcations. Int J Cardiol 283:78–83
doi: 10.1016/j.ijcard.2018.11.139
Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, ESC Scientific Document Group (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40:87–165
Rigatelli G, Zuin M, Dell’Avvocata F, Vassilev D, Daggubati R, Nguyen T, Van Viet TN, Foin N (2017) Evaluation of coronary flow conditions in complex coronary artery bifurcations stenting using computational fluid dynamics: impact of final proximal optimization technique on different double-stent techniques. Cardiovasc Revasc Med 18:233–240
doi: 10.1016/j.carrev.2017.01.002
Rigatelli G, Zuin M, Vassilev D, Dinh H, Giatti S, Carraro M, Zanon F, Roncon L, Dung HT (2019) Culotte versus the novel nano-crush technique for unprotected complex bifurcation left main stenting: difference in procedural time, contrast volume and X-ray exposure and 3-years outcomes. Int J Cardiovasc Imaging 35:207–214
doi: 10.1007/s10554-018-1497-8
Rigatelli G, Zuin M, Dell'Avvocata F, Vassilev D, Daggubati R, Nguyen T, Nguyễn MTN, Foin N (2018) Complex coronary bifurcation treatment by a novel stenting technique: bench test, fluid dynamic study and clinical outcomes.Catheter Cardiovasc Interv 92:907–914
Ad N, Holmes SD, Patel J, Pritchard G, Shuman DJ, Halpin L (2016) Comparison of EuroSCORE II, original EuroSCORE, and the society of thoracic surgeons risk score in cardiac surgery patients. Ann Thorac Surg 102:573–579
doi: 10.1016/j.athoracsur.2016.01.105
Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 1:219–227
pubmed: 19758907
Medina A, Suarez de Lezo J, Pan M (2006) A new classification of coronary bifurcation lesions. Rev EspCardiol 59:183
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD (2019) ESC Scientific Document Group, fourth universal definition of myocardial infarction (2018). Eur Heart J 40:237–269
doi: 10.1093/eurheartj/ehy462
Mehran R, Dangas G, Abizaid AS (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100:1872–1878
doi: 10.1161/01.CIR.100.18.1872
Chen SL, Sheiban I, Xu B, Jepson N, Paiboon C, Zhang JJ, Ye F, Sansoto T, Kwan TW, Lee M, Han YL, Lv SZ, Wen SY, Zhang Q, Wang HC, Jiang TM, Wang Y, Chen LL, Tian NL, Cao F, Qiu CG, Zhang YJ, Leon MB (2014) Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts). JACC Cardiovasc Interv 7:1266–76
Rigatelli G, Zuin M, Ronco F, Caprioglio F, Cavazzini D, Giatti S, Braggion G, Perilli S, Nguyen VT (2018) Usefulness of the Finet law to guide stent size selection in ostial left main stenting: comparison with standard angiographic estimation. Cardiovasc Revasc Med 19:751–754
doi: 10.1016/j.carrev.2018.04.005
Kang SJ, Lee JY, Ahn JM, Mintz GS, Kim WJ, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Park SW, Park SJ (2011) Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity. Circ Cardiovasc Interv 4:65–71
doi: 10.1161/CIRCINTERVENTIONS.110.959148
Chieffo A, Latib A, Caussin C, Presbitero P, Galli S, Menozzi A, Varbella F, Mauri F, Valgimigli M, Arampatzis C, Sabate M, Erglis A, Reimers B, Airoldi F, Laine M, Palop RL, Mikhail G, Maccarthy P, Romeo F, Colombo A (2013) A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J 65:65–72
doi: 10.1016/j.ahj.2012.09.017
Rigatelli G, Zuin M, Baracca E, Galasso P, Carraro M, Mazza A, Lanza D, Roncon L, Daggubati R (2019) Long-term clinical outcomes of isolated ostial left anterior descending disease treatment: Ostial stenting versus left main cross-over stenting. Cardiovasc Revasc Med. https://doi.org/10.1016/j.carrev.2019.01.030
Ormiston JA, Webster MW, Webber B, Stewart JT, Ruygrok PN, Hatrick RI (2008) The “crush” technique for coronary artery bifurcation stenting: insights from micro-computed tomographic imaging of bench deployments. JACC Cardiovasc Interv 1:351–357
doi: 10.1016/j.jcin.2008.06.003
Chen X, Li X, Zhang JJ, Han Y, Kan J, Chen L, Qiu C, Santoso T, Paiboon C, Kwan TW, Sheiban I, Leon MB, Stone GW, Chen SL, Investigators DKCRUSH-V (2019) 3-year outcomes of the DKCRUSH-V trial comparing DK crush with provisional stenting for left main bifurcation lesions. JACC Cardiovasc Interv 12:1927–1937
doi: 10.1016/j.jcin.2019.04.056
Chen SL, Xu B, Han YL, Sheiban I, Zhang JJ, Ye F, Kwan TW, Paiboon C, Zhou YJ, Lv SZ, Dangas GD, Xu YW, Wen SY, Hong L, Zhang RY, Wang HC, Jiang TM, Wang Y, Sansoto T, Chen F, Yuan ZY, Li WM, Leon MB (2015) Clinical outcome after DK crush versus culotte stenting of distal left main bifurcation lesions: the 3-year follow-up results of the DKCRUSH-III study. JACC Cardiovasc Interv 8:1335–1342
doi: 10.1016/j.jcin.2015.05.017
Iannaccone M, Gatti P, Barbero U, Bassignana A, Gallo D, de Benedictis M, Helft G, Morbiducci U, Doronzo B, D'Ascenzo F (2019) Impact of strut thickness and number of crown and connectors on clinical outcomes on patients treated with second-generation drug eluting stent. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.28228
Chen SL, Santoso T, Zhang JJ, Ye F, Xu YW, Fu Q, Kan J, Zhang FF, Zhou Y, Xie DJ, Kwan TW (2017). Clinical outcome of double kissing crush versus provisional stenting of coronary artery bifurcation lesions: the 5-year follow-up results from a randomized and multicenter DKCRUSH-II study (Randomized study on double kissing crush technique versus provisional stenting technique for coronary artery bifurcation lesions) (2017). Circ Cardiovasc Interv 10:e004497. https://doi.org/10.1161/CIRCINTERVENTIONS.116.00449
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Authors/Task Force Members (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 36:1953–2041. https://doi.org/10.1097/HJH.0000000000001940
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41:111–188

Auteurs

Gianluca Rigatelli (G)

Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Viale Tre Martiri 140, 45100, Rovigo, Italy. jackyheart@libero.it.

Marco Zuin (M)

Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Viale Tre Martiri 140, 45100, Rovigo, Italy.
School of Medicine, University of Ferrara, Ferrara, Italy.

Dobrin Vassilev (D)

Head of Cardiology, Alexandroska University Hospital Medical School, Sofia, Bulgaria.

Huy Dinh (H)

Department of Interventional Cardiology, Tam Duc Heart Hospital, Ho Chi Minh City, Vietnam.

Fabio Dell'Avvocata (F)

Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Viale Tre Martiri 140, 45100, Rovigo, Italy.

Nguyen Van Tan (N)

Department of Interventional Cardiology, Thong Nhat Hospital, Ho Chi Minh City, Vietnam.

Nguyen Nghia (N)

Department of Interventional Cardiology, Cho Ray Hospital, Ho Chi Minh City, Vietnam.

Federico Ronco (F)

Interventional Cardiology Unit, Department of Cardiology, Mestre Hospital, Mestre, Italy.

Loris Roncon (L)

Division of Cardiology, Rovigo General Hospital, Rovigo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH